휴온스글로벌

084110KOSDAQ

52.5 / 100

Reference Date: 2026-10-23

Financial Score28.0 / 40

News Sentiment12.5 / 25

Momentum5.0 / 20

Disclosure7.0 / 15

AI Analysis: the debt ratio is very low with excellent financial health but Operating Profit is on a declining trend. Declined 6.1% over the past month, with no recent news.

Company InformationBased on 2025 Annual Report

Business Overview

Hyunohs Global is a holding company under the Hyunohs Group, managing 13 subsidiaries across pharmaceuticals, medical devices, biopharmaceuticals, and health supplements. Key operations include Hyunohs' pharmaceutical manufacturing, Hyunmedics' botulinum toxin and filler development, Hyunohs Biopharma's biopharmaceutical research, and Hyunohs Meditech's medical device production. Primary revenue streams include brand royalties and dividends from subsidiaries.

Number of Employees

121people

Average Salary

62.0M KRW

Score Calculation Basis

Detailed Financial Score

PER

8.77Industry Average 15.006.5Point

Lower than industry avg (good)

PBR

0.24Industry Average 1.207.0Point

Half of industry avg (excellent)

ROE

7.96Industry Average 8.002.5Point

Below industry avg

Debt Ratio

13.66Industry Average 100.008.0Point

Half of industry avg (excellent)

Trend 2023~20254.0 / 10 points

Revenue Growth Rate

2.0 / 3

Avg ▲5.7% (2-year basis)

Operating Profit Growth Rate

0.0 / 3

Avg ▼10.8% (2-year basis)

ROE Trend

2.0 / 4

Avg ROE 8.7% (declining, 3yr)

Detailed News Sentiment

0 totalPositive 0Neutral 0Negative 0

Detailed Momentum

52-week position1.0Point

Near 52w low (0%, downtrend)

Current 20,750Won52-week high 75,30052-week low 20,600

1-month return2.0Point

1m -6.11% (slight drop)

Volume trend2.0Point

Volume decreasing

Detailed Disclosure

1 totalPositive 0Neutral 0Negative 1

Negative불성실공시법인미지정 (지정유예)2026-10-21